Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

TEMPORARY REMOVAL: Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015-2023

Holt F. et al, (2024), Clinical Oncology

Which real indications remain for mastectomy?

Cardoso MJ. et al, (2024), Lancet Reg Health Am, 33

The Lancet Breast Cancer Commission.

Coles CE. et al, (2024), Lancet

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.

Potter S. et al, (2024), BMJ open, 14

Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study.

Brown J. et al, (2024), J Bone Miner Res, 39, 8 - 16

Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.

Mannu GS. et al, (2024), BMJ, 384

Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer (PRIME II)

Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 217 - 220

Effect of Radiotherapy after Breast-Conserving Surgery on 10-Year Recurrence and 15-Year Breast Cancer Death: Meta-Analysis of Individual Patient Data for 10,801 Women in 17 Randomised Trials

Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 221 - 224

Effect of Radiotherapy after Mastectomy and Axillary Surgery on 10-Year Recurrence and 20-Year Breast Cancer Mortality: Meta-Analysis of Individual Patient Data for 8135 Women in 22 Randomised Trials

Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 229 - 232

Hypofractionated Breast Radiotherapy for 1 Week versus 3 Weeks (FAST-Forward): 5-Year Efficacy and Late Normal Tissue Effects; Results from a Multicentre, Non-Inferiority, Randomised, Phase 3 Trial

Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 233 - 236

Whole-Breast Irradiation with or without a Boost for Patients Treated with Breast-Conserving Surgery for Early Breast Cancer: 20-Year Follow-Up of a Randomised Phase 3 Trial

Haris PA. and Dodwell D., (2024), 50 Landmark Papers: Every Breast Surgeon Should Know, 225 - 228

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Postoperative radiation therapy for early breast cancer

Oliveros S. and Dodwell D., (2023), Breast Cancer Management for Surgeons: An Examination Guide, 287 - 305

Mastectomy patterns among older women with early invasive breast cancer in England and Wales: A population-based cohort study.

Miller K. et al, (2023), J Geriatr Oncol, 14

Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England.

Gannon MR. et al, (2023), Br J Cancer

Treatment-related acute toxicity with adjuvant systemic treatment among patients with HER2-positive early invasive breast cancer: a national population-based cohort study

Gannon MR. et al, (2023), BMJ Oncology, 2

Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study.

Clift AK. et al, (2023), Lancet Digit Health, 5, e571 - e581

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data.

Gannon MR. et al, (2023), Cancer Epidemiol, 86

Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population-based Systemic Anti-Cancer Treatment (SACT) dataset.

Pilleron S. et al, (2023), J Geriatr Oncol, 14

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?